Cholangiocarcinoma: treatment with sorafenib extended life expectancy to greater than four years.
about
Effectiveness and safety of sorafenib in the treatment of unresectable and advanced intrahepatic cholangiocarcinoma: a pilot study.Role of drug-dependent transporter modulation on the chemosensitivity of cholangiocarcinoma.Automated selection of aptamers against cholangiocarcinoma cells on an integrated microfluidic platform.Emerging role of precision medicine in biliary tract cancersPersonalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma
P2860
Cholangiocarcinoma: treatment with sorafenib extended life expectancy to greater than four years.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Cholangiocarcinoma: treatment ...... cy to greater than four years.
@en
Cholangiocarcinoma: treatment ...... cy to greater than four years.
@nl
type
label
Cholangiocarcinoma: treatment ...... cy to greater than four years.
@en
Cholangiocarcinoma: treatment ...... cy to greater than four years.
@nl
prefLabel
Cholangiocarcinoma: treatment ...... cy to greater than four years.
@en
Cholangiocarcinoma: treatment ...... cy to greater than four years.
@nl
P2093
P2860
P1476
Cholangiocarcinoma: treatment ...... cy to greater than four years.
@en
P2093
Hareesha Rao Chakunta
Mark A Kaplan
Ravi Sunderkrishnan
Reza Mostofi
P2860
P356
10.3978/J.ISSN.2078-6891.2013.031
P577
2013-12-01T00:00:00Z